EUVIMEDEUVIMED entdecken
Crossref

Ataxia with giant axonopathy in Acbd5 -deficient mice halted by adeno-associated virus gene therapy

Luis Granadeiro, Violeta Enríquez Zarralanga, Ricardo Rosa, Filipa Franquinho, Sofia Lamas, Pedro Brites iD

Brain · 2024

DOI: 10.1093/brain/awad407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Luis Granadeiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurolipid Biology, Instituto de Investigação e Inovação em Saúde da Universidade do Porto - i3S and Instituto de Biologia Molecular e Celular - IBMC…. Hauptthemen laut MEDLINE: Fatty Acids, Adrenoleukodystrophy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Fundação para a Ciência e a Tecnologia-FCT, National Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acyl-CoA binding domain containing 5 (ACBD5) is a critical player in handling very long chain fatty acids (VLCFA) en route for peroxisomal β-oxidation. Mutations in ACBD5 lead to the accumulation of VLCFA and patients present retinal dystrophy, ataxia, psychomotor delay and a severe leukodystrophy. Using CRISPR/Cas9, we generated and characterized an Acbd5 Gly357* mutant allele. Gly357* mutant mice recapitulated key features of the human disorder, including reduced survival, impaired locomotion and reflexes, loss of photoreceptors, and demyelination. The ataxic presentation of Gly357* mice involved the loss of cerebellar Purkinje cells and a giant axonopathy throughout the CNS. Lipidomic studies provided evidence for the extensive lipid dysregulation caused by VLCFA accumulation. Following a proteomic survey, functional studies in neurons treated with VLCFA unravelled a deregulated cytoskeleton with reduced actin dynamics and increased neuronal filopodia. We also show that an adeno-associated virus-mediated gene delivery ameliorated the gait phenotypes and the giant axonopathy, also improving myelination and astrocyte reactivity. Collectively, we established a mouse model with significance for VLCFA-related disorders. The development of relevant neuropathological outcomes enabled the understanding of mechanisms modulated by VLCFA and the evaluation of the efficacy of preclinical therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsAdrenoleukodystrophyHumansMiceAnimalsDependovirusProteomicsAtaxiaGenetic Therapy

Stichwörter der Autor:innen

AAV therapyCNS axonopathyVLCFAgiant axonsperoxisomal β-oxidation

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • Neurolipid Biology, Instituto de Investigação e Inovação em Saúde da Universidade do Porto - i3S and Instituto de Biologia Molecular e Celular - IBMC, 4200-135 Porto, Portugal.
  • Graduate Program in Molecular and Cell Biology, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, 4050-313 Porto, Portugal.
  • Animal Facility, Instituto de Investigação e Inovação em Saúde da Universidade do Porto - i3S, 4200-135 Porto, Portugal.

ORCID-Profile: Pedro Brites

Förderung

  • Fundação para a Ciência e a Tecnologia-FCT
  • National Funds

Zitieren

APA

Granadeiro, L., Zarralanga, V. E., Rosa, R., Franquinho, F., Lamas, S., & Brites, P. (2024). Ataxia with giant axonopathy in Acbd5 -deficient mice halted by adeno-associated virus gene therapy. Brain. https://doi.org/10.1093/brain/awad407

Vancouver

Granadeiro L, Zarralanga VE, Rosa R, Franquinho F, Lamas S, Brites P. Ataxia with giant axonopathy in Acbd5 -deficient mice halted by adeno-associated virus gene therapy. Brain. 2024. doi:10.1093/brain/awad407

BibTeX
@article{Granadeiro2024,
  author = {Granadeiro, Luis and Zarralanga, Violeta Enríquez and Rosa, Ricardo and Franquinho, Filipa and Lamas, Sofia and Brites, Pedro},
  title = {Ataxia with giant axonopathy in Acbd5 -deficient mice halted by adeno-associated virus gene therapy},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awad407}
}
Kostenlos starten →